Phoenix, Arizona–(Newsfile Corp. – May 23, 2022) – The Stock Day Podcast welcomed BioLargo, Inc. (OTCQB: BLGO), a company that invents, develops, and commercializes innovative technologies in the cleantech space, including for PFAS contamination, advanced water and wastewater treatment, industrial odor and VOC control, air quality control, and infection control. President and CEO of BioLargo, Dennis P. Calvert, joined Stock Day host Sever Copley for an interview on the Stock Day Podcast.
Copley began by asking about the company’s background and vision. “BioLargo has over a decade of R&D behind it, and we’ve been inventing chemistries, technical solutions, and all sorts of innovations to help solve some of the biggest problems that face our planet, including clean air, clean water, and a cleaner Earth,” explained Calvert. “All of that R&D is beginning to pay off through commercialization.”
Copley then commented on the company’s recently announced record-breaking quarter and asked about the drivers behind this success. “Most of this is organic growth, so it is a very exciting time,” answered Calvert. “It was a 69% growth over last year’s quarter,” he added, noting that the company brought in nearly a million in revenue in the first quarter of 2022.
The conversation then turned to the company’s technology that treats water contaminated with per- and polyfluoroalkyl substances (PFAS). Calvert explained, “PFAS are ‘forever chemicals’ which have been used for about 35 years in all sorts of plastic coatings… PFAS has been linked to adverse health effects, including cancer.” He added, “We have an innovation that we believe will be the number one technical solution for concentrating, extracting, and removing those contaminants from nature.”
“What is the status of your PFAS treatment technology division?” asked Copley. “We’ve just completed some testing with one of the largest [municipal water agencies] in the world, and that data and proof of claim has become instrumental,” said Calvert. “We achieved what is called a non-detect status, which means the level was so low that it was below the level of being detectable by current technology,” he said, before elaborating on the company’s growing list of prospects and channel partners, as well as a pipeline of potential projects.
Copley then turned the conversation to BioLargo’s partnership with Garratt-Callahan, the largest privately owned water treatment company in North America. The two companies have partnered to bring a new wastewater treatment technology to market. “We have developed a system that has been validated, which we call the Minimum Liquid Discharge (MLD) [system],” said Calvert. “Garratt-Callahan asked us to design, make, and prove up this machine, and in exchange we would become the supply chain partner and they would manage distribution.”
Calvert discussed the plan for rolling out the MLD system with Garratt-Callahan customers, “We are in current negotiations with customers… It is about a year and a half of work coming to fruition on the commercial side and we’re pretty excited about the next few steps.”
“Could you tell us about the new contract with the waste-to-energy conversion plant project in South America?” asked Copley. Calvert explained that BioLargo has been contracted for the first phase of the project, a comprehensive project planning stage (i.e., “feasibility study”), and may be hired for additional stages with greater potential value. He finished by adding that if the project advances to completion, the total project cost could reach a half billion dollars over its lifetime of four or more years.
To hear Dennis Calvert’s entire interview, follow the link to the podcast here: https://audioboom.com/posts/8088354-biolargo-inc-discusses-record-breaking-quarter-on-the-stock-day-podcast
About BioLargo, Inc.
BioLargo, Inc. (OTCQB: BLGO) invents, develops, and commercializes innovative technologies in the cleantech space, including for PFAS contamination, advanced water and wastewater treatment, industrial odor and VOC control, air quality control, and infection control. With over 13 years of extensive R&D, BioLargo holds a wide array of issued patents, maintains a robust pipeline of products, and provides full-service environmental engineering. Our approach is to invent or acquire novel technologies and develop them to maturity through our operating subsidiaries. We have developed a number of key channel partnerships to support the reach of our products and services and maximize their commercial potential. With a keen emphasis on collaborations with academic, municipal, and commercial organizations and associations, BioLargo has proven itself with over 80 awarded grants and numerous pilot projects. We monetize through direct sales, recurring service contracts, licensing agreements, strategic joint venture formation and/or the sale of the IP. See our website at www.BioLargo.com.
Dennis P. Calvert
President and CEO, BioLargo, Inc.
Safe Harbor Act
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include without limitation those about BioLargo’s (the “Company”) expectations regarding anticipated revenue and plans for future operations, and may be identified by words such as “we believe”. These statements involve risks and uncertainties, and actual results may differ materially from any future results expressed or implied by the forward-looking statements. Risks and uncertainties include without limitation: the effect of the COVID-19 pandemic on the Company’s business, results of operations, financial condition, and stock price; the effect of global and regional economic conditions on the Company’s business, including effects on purchasing decisions by consumers and businesses; the ability of the Company to compete in markets that are highly competitive and subject to rapid technological change; the ability of the Company to manage frequent introductions and transitions of products and services, including delivering to the marketplace, and stimulating customer demand for, new products, services, and technological innovations on a timely basis; the dependency of the Company on the performance of distributors of the Company’s products. More information on these risks and other potential factors that could affect the Company’s business and financial results is included in the Company’s filings with the SEC, including in the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of the Company’s most recently filed periodic reports on Form 10-K and Form 10-Q and subsequent filings. The Company assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates.
About The “Stock Day” Podcast
Founded in 2013, Stock Day is the fastest growing media outlet for Nano-Cap and Micro-Cap companies. It educates investors while simultaneously working with penny stock and OTC companies, providing transparency and clarification of under-valued, under-sold Micro-Cap stocks of the market. Stock Day provides companies with customized solutions to their news distribution in both national and international media outlets. The Stock Day Podcast is the number one radio show of its kind in America.
Stock Day Media